More articles from Clinical Investigations (Human)

You have access
Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions
Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe A. Haberkorn and Manuel Röhrich

Journal of Nuclear Medicine May 26, 2022, jnumed.122.264069; DOI: https://doi.org/10.2967/jnumed.122.264069
You have access
¹⁸F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors
Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale

Journal of Nuclear Medicine May 19, 2022, jnumed.122.263984; DOI: https://doi.org/10.2967/jnumed.122.263984
You have access
First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using ¹⁸F-labeled Active-Site Inhibited Factor VII (¹⁸F-ASIS): Potential as Companion Diagnostic
Mathias Loft, Camilla Christensen, Malene Martini Clausen, Esben Andreas Carlsen, Carsten Palnaes Hansen, Niels Kroman, Seppo Wang Langer, Claus Hoegdall, Jacob Madsen, Nic Gillings, Carsten Haagen Nielsen, Thomas Levin Klausen, Soeren Holm, Annika Loft, Anne Kiil Berthelsen and Andreas Kjaer

Journal of Nuclear Medicine May 19, 2022, jnumed.122.264068; DOI: https://doi.org/10.2967/jnumed.122.264068
You have access
Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma – the HEPAR Primary study
Margot Thea Maria Reinders, Karel J. van Erpecum, Maarten L. J. Smits, Arthur Johannes Anthonius Theodorus Braat, Joep de Bruijne, Rutger C.G. Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix Lam

Journal of Nuclear Medicine May 19, 2022, jnumed.122.263823; DOI: https://doi.org/10.2967/jnumed.122.263823
You have access
Total-Body ¹⁸F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations
Yasser Abdelhafez, Siba P. Raychaudhuri, Dario Mazza, Soumajyoti Sarkar, Heather L. Hunt, Kristin McBride, Mike Nguyen, Denise T. Caudle, Benjamin A. Spencer, Negar A. Omidvari, Heejung Bang, Simon R. Cherry, Lorenzo Nardo, Ramsey Derek Badawi and Abhijit J Chaudhari

Journal of Nuclear Medicine May 19, 2022, jnumed.121.263774; DOI: https://doi.org/10.2967/jnumed.121.263774
You have access
Using, ⁶⁸Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice.
Chloé S Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R Sautois and Nadia Withofs

Journal of Nuclear Medicine May 12, 2022, jnumed.121.263611; DOI: https://doi.org/10.2967/jnumed.121.263611
You have access
Correlation of ⁶⁸Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru

Journal of Nuclear Medicine May 12, 2022, jnumed.122.263971; DOI: https://doi.org/10.2967/jnumed.122.263971
You have access
¹⁸F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
Konstantin Messerschmidt, Henryk Barthel, Matthias Brendel, Cordula Scherlach, Karl-Titus Hoffmann, Boris-Stephan Rauchmann, Michael Rullmann, Kenneth Marek, Victor L. Villemagne, Jost-Julian Rumpf, Dorothee Saur, Matthias L. Schroeter, Andreas Schildan, Marianne Patt, Leonie Beyer, Mengmeng Song, Carla Palleis, Sabrina Katzdobler, Urban M. Fietzek, Gesine Respondek, Maximilian Scheifele, Alexander Nitschmann, Christian Zach, Olivier Barret, Jennifer Madonia, David Russell, Andrew W Stephens, Norman Koglin, Sigrun Roeber, Jochen Herms, Kai Boetzel, Peter Bartenstein, Johannes Levin, John P. Seibyl, Günter Höglinger, Joseph Classen and Osama Sabri

Journal of Nuclear Medicine May 5, 2022, jnumed.121.262854; DOI: https://doi.org/10.2967/jnumed.121.262854
You have access
⁶⁸Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment
Farshad Moradi, Heying Duan, Hong Song, Guido A Davidzon, Benjamin I Chung, Alan E C Thong, Andreas M Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru

Journal of Nuclear Medicine May 5, 2022, jnumed.122.263897; DOI: https://doi.org/10.2967/jnumed.122.263897
You have access
⁸⁹Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer
Sarah R Verhoeff, Pim P van de Donk, Erik H.J.G. Aarntzen, Sjoukje F Oosting, Adrienne H Brouwers, Iris H.C. Miedema, Jens Voortman, Willemien C. Menke-van der Houven van Oordt, Ronald Boellaard, Dennis Vriens, Marije Slingerland, Rick Hermsen, Ilse van Engen-van Grunsven, Sandra Heskamp and Carla M.L. van Herpen

Journal of Nuclear Medicine May 5, 2022, jnumed.121.263470; DOI: https://doi.org/10.2967/jnumed.121.263470

Main menu

User menu

Search

More articles from Clinical Investigations (Human)

Pages